Thermo Fisher Scientific (TMO) Tops Q2 EPS by 13c, Revenues Beat; Boosts FY18 EPS/Revenue Outlook

Go back to Thermo Fisher Scientific (TMO) Tops Q2 EPS by 13c, Revenues Beat; Boosts FY18 EPS/Revenue Outlook

Thermo Fisher Scientific (TMO) PT Raised to $242 at Morgan Stanley

July 26, 2018 9:02 AM EDT

Morgan Stanley raised its price target on Thermo Fisher Scientific (NYSE: TMO) to $242.00 (from $233.00) while maintaining a Overweight rating.

... More

Thermo Fisher Scientific (TMO) PT Raised to $250 at Barclays

July 26, 2018 5:48 AM EDT

Barclays raised its price target on Thermo Fisher Scientific (NYSE: TMO) to $250.00 (from $245.00) while maintaining a Overweight rating.

... More

Thermo Fisher Scientific (TMO) PT Raised to $260 at Deutsche Bank

July 25, 2018 1:57 PM EDT

Deutsche Bank raised its price target on Thermo Fisher Scientific (NYSE: TMO) to $260.00 (from $245.00) while maintaining a Buy rating following results.

Analyst Dan Leonard said TMO's upwardly revised organic sales growth guidance of 6% appears conservative. End markets were robust, led by China and biopharma.

... More

Thermo Fisher Scientific (TMO) PT Raised to $300 at JPMorgan

July 25, 2018 1:46 PM EDT

JPMorgan raised its price target on Thermo Fisher Scientific (NYSE: TMO) to $300.00 (from $250.00) while maintaining a Overweight rating.

Analyst Tycho Peterson says the broad-based flow of momentum paves a path for organic acceleration and he continues to like the setup in the... More